[PDF] Top 20 Caracterizacin de los pacientes con reparaciones de prtesis estomatolgica
Has 10000 "Caracterizacin de los pacientes con reparaciones de prtesis estomatolgica" found on our website. Below are the top 20 most common "Caracterizacin de los pacientes con reparaciones de prtesis estomatolgica".
M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
... stage ovarian cancers ...when M-CSF was combined with conventional markers, sensitivity levels improved to 80% - stage I, to 92–100% in stages II-IV and to 91% or 96% in every histological sub-type ... See full document
58
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
... curve; CA 125: Carbohydrate antigen 125; CA19 – 9: Carbohydrate antigen 19 – 9; CCL: CC chemokine; CEA: Carcinoembryonic antigen; CMIA: Chemiluminescent microparticle immunoassay; CRP: C Reactive ... See full document
6
The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
... for CA 125 or HE4 alone (92% and 72%; respectively) in Asian women [60], or distinctly higher values of these diagnos- tic criteria for HE4 than CA125 though for comparison of ... See full document
14
The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer
... gynecological cancer, such as endometrial, pancreatic, lung, breast and colorectal cancer ...In patients with endometriosis CA125 levels can be ...peripheral biomarker of endometriosis ...and ... See full document
8
High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
... in patients with endometriosis irrespective of the extent of endometriosis or the pres- ence of endometrioma, in contrast to CA ...that HE4 serum concentrations were within normal range in ... See full document
22
Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
... recurrent ovarian tumor tissues: heat map shows eight downregulated (fold change ...into ovarian cancer cells, A2780 and OVCAR8, confirmed by real-time polymerase chain reaction and ...in ... See full document
41
<p>Evaluation of p16 in Epithelial Ovarian Cancer for a 10-Year Study in Northeast China: Significance of HPV in Correlation with PD-L1 Expression</p>
... HPV infection may result in a large spectrum of epithe- lial lesions. Previous studies have indicated that p16 may enhance the immunogenicity of dendritic cells (DCs), through cyclin-dependent pathways and Th1 cytokine ... See full document
10
Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer
... 13 patients admitted for six cycles of first line chemotherapy (paclitaxel/carboplatin; Hungarian OEP Chemotherapy protocol # ...All patients, aged 41 to 73 y (mean, 60 y), underwent radical gynecological ... See full document
24
CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
... Epithelial ovarian cancer (EOC) is the most lethal gyneco- logic malignancy in the United States ...EOC patients, achieving complete cure is ...EOC patients develop recur- rent disease ... See full document
14
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
... lung cancer (NSCLC) over the past few decades, the 5-year survival rate has not improved much primarily because of initial diagnosis at a late ...of patients with NSCLC are ... See full document
8
<p>Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer</p>
... (including cancer) by regulating gene expression via multiple ...that patients who suffered from type 2 diabetes mellitus had upregulated hsa_circ_0054633 in the peripheral blood ...gastric cancer, ... See full document
7
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases
... examined HE4 concentrations in the peritoneal ovarian neoplastic fluid, also in a variety of be- nign diseases and other cancers, not only gynecological ...The HE4 con- centrations in the peritoneal ... See full document
14
<p>Parity as a Prognostic Factor in Patients with Advanced-Stage Epithelial Ovarian Cancer</p>
... EOC patients varied across ...that patients with endometrioid type EOC had a worse OS than serous histological ...ASEOC patients in the current ...ASEOC patients. 2 Chang et al showed that ... See full document
12
Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
... The CA-125 antigen was developed in the late 1970s and was first reported in 1981 by Bast et ...serous ovarian cancer cell line ...observing ovarian or peritoneal malignances ...the ... See full document
15
KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer
... the proteins from each sample were separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). The membranes were blocked with 5% skim milk, incubated with primary ... See full document
106
Review Article Prognostic roles of high TIMP-1 expression in patients with solid tumors: a meta-analysis
... death, cancer is a public health problem worldwide ...of cancer is dependent not only on early diagnosis, but also proper therapy strate- gies based on forecasting of patient ...Therefore, new tumor ... See full document
55
Correlation of Sonographic Morphologic Index and CA-125 in predicting the Nature of Ovarian Tumor
... with ovarian tumor irrespective of age and menopausal status undergoing surgery in the research institute were included in the ...of ovarian carcinoma or already operated for ovarian carcinoma, any ... See full document
78
Mainstreamed Genetic Testing in Ovarian Cancer: Patient Experience of the Testing Process
... The Testing Experiences measure designed by B Rahman evaluated various aspects of the mainstreamed genetic testing pathway. One of the statements sought to determine whether the level of support provided, by the tertiary ... See full document
9
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine
... (HCC) patients, PI-88 treatment was administered over nine, 4-week treatment cycles, followed by a 12-week treatment-free ...in patients with advanced solid tumors, the compound was found to be ... See full document
103
Diagnostic value of serum cancer antigen 125 in ovarian cancer patients
... with ovarian cancer and comparing them to symptoms in women without ovarian cancer demonstrate that patients with ovarian cancer are symptomatic for a variable period ... See full document
6
Related subjects